BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

812 related articles for article (PubMed ID: 24225968)

  • 1. Translating genomics in cancer care.
    Bombard Y; Bach PB; Offit K
    J Natl Compr Canc Netw; 2013 Nov; 11(11):1343-53. PubMed ID: 24225968
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Controversy and debate on clinical genomics sequencing-paper 1: genomics is not exceptional: rigorous evaluations are necessary for clinical applications of genomic sequencing.
    Wilson BJ; Miller FA; Rousseau F
    J Clin Epidemiol; 2017 Dec; 92():4-6. PubMed ID: 28870871
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Translating personalized genomic medicine into clinical practice: evidence, values, and health policy.
    Bombard Y
    Genome; 2015 Dec; 58(12):491-7. PubMed ID: 26577841
    [No Abstract]   [Full Text] [Related]  

  • 4. Integrating genomics into clinical oncology: ethical and social challenges from proponents of personalized medicine.
    McGowan ML; Settersten RA; Juengst ET; Fishman JR
    Urol Oncol; 2014 Feb; 32(2):187-92. PubMed ID: 24445286
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genomic medicine and risk prediction across the disease spectrum.
    Kotze MJ; Lückhoff HK; Peeters AV; Baatjes K; Schoeman M; van der Merwe L; Grant KA; Fisher LR; van der Merwe N; Pretorius J; van Velden DP; Myburgh EJ; Pienaar FM; van Rensburg SJ; Yako YY; September AV; Moremi KE; Cronje FJ; Tiffin N; Bouwens CS; Bezuidenhout J; Apffelstaedt JP; Hough FS; Erasmus RT; Schneider JW
    Crit Rev Clin Lab Sci; 2015; 52(3):120-37. PubMed ID: 25597499
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Next generation sequencing in cancer: opportunities and challenges for precision cancer medicine.
    Paolillo C; Londin E; Fortina P
    Scand J Clin Lab Invest Suppl; 2016; 245():S84-91. PubMed ID: 27542004
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Integrating precision cancer medicine into healthcare-policy, practice, and research challenges.
    Bertier G; Carrot-Zhang J; Ragoussis V; Joly Y
    Genome Med; 2016 Oct; 8(1):108. PubMed ID: 27776531
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Personalized medicine and genomics: challenges and opportunities in assessing effectiveness, cost-effectiveness, and future research priorities.
    Conti R; Veenstra DL; Armstrong K; Lesko LJ; Grosse SD
    Med Decis Making; 2010; 30(3):328-40. PubMed ID: 20086232
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oncotyrol--Center for Personalized Cancer Medicine: Methods and Applications of Health Technology Assessment and Outcomes Research.
    Siebert U; Jahn B; Rochau U; Schnell-Inderst P; Kisser A; Hunger T; Sroczynski G; Mühlberger N; Willenbacher W; Schnaiter S; Endel G; Huber L; Gastl G;
    Z Evid Fortbild Qual Gesundhwes; 2015; 109(4-5):330-40. PubMed ID: 26354133
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of genomics on the future of medicine and health.
    Mattick JS; Dziadek MA; Terrill BN; Kaplan W; Spigelman AD; Bowling FG; Dinger ME
    Med J Aust; 2014 Jul; 201(1):17-20. PubMed ID: 24999876
    [No Abstract]   [Full Text] [Related]  

  • 11. [Molecular-Genetic Diagnosis and Molecular-Targeted Therapy in Cancer: Challenges in the Era of Precision Medicine].
    Miyachi H
    Rinsho Byori; 2015 Oct; 63(10):1188-93. PubMed ID: 26897855
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Genomic Era of Clinical Oncology: Integrated Genomic Analysis for Precision Cancer Care.
    Surrey LF; Luo M; Chang F; Li MM
    Cytogenet Genome Res; 2016; 150(3-4):162-175. PubMed ID: 28002823
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multilevel research and the challenges of implementing genomic medicine.
    Khoury MJ; Coates RJ; Fennell ML; Glasgow RE; Scheuner MT; Schully SD; Williams MS; Clauser SB
    J Natl Cancer Inst Monogr; 2012 May; 2012(44):112-20. PubMed ID: 22623603
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hereditary nonpolyposis colorectal cancer: diagnostic strategies and their implications.
    Bonis PA; Trikalinos TA; Chung M; Chew P; Ip S; DeVine DA; Lau J
    Evid Rep Technol Assess (Full Rep); 2007 May; (150):1-180. PubMed ID: 17764220
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Direct-to-consumer personal genome testing and cancer risk prediction.
    Bellcross CA; Page PZ; Meaney-Delman D
    Cancer J; 2012; 18(4):293-302. PubMed ID: 22846729
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Psychiatric Genomics and Mental Health Treatment: Setting the Ethical Agenda.
    Kong C; Dunn M; Parker M
    Am J Bioeth; 2017 Apr; 17(4):3-12. PubMed ID: 28328372
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The SickKids Genome Clinic: developing and evaluating a pediatric model for individualized genomic medicine.
    Bowdin SC; Hayeems RZ; Monfared N; Cohn RD; Meyn MS
    Clin Genet; 2016 Jan; 89(1):10-9. PubMed ID: 25813238
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Ethical and social issues associated with genomic medicine].
    Barazzetti G; Kaufmann A; Benaroyo L
    Praxis (Bern 1994); 2014 May; 103(10):573-7. PubMed ID: 24800769
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Essential elements of personalized medicine.
    Burke W; Brown Trinidad S; Press NA
    Urol Oncol; 2014 Feb; 32(2):193-7. PubMed ID: 24321254
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and analytical validation of a 25-gene next generation sequencing panel that includes the BRCA1 and BRCA2 genes to assess hereditary cancer risk.
    Judkins T; Leclair B; Bowles K; Gutin N; Trost J; McCulloch J; Bhatnagar S; Murray A; Craft J; Wardell B; Bastian M; Mitchell J; Chen J; Tran T; Williams D; Potter J; Jammulapati S; Perry M; Morris B; Roa B; Timms K
    BMC Cancer; 2015 Apr; 15():215. PubMed ID: 25886519
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 41.